The clinical impact of hydroresponsive dressings in dynamic wound healing: Part I.

HydroClean HydroTac PUSH score Resposorb debridement hydroresponsive wound dressing wound wound bed preparation wound care wound healing wounds

Journal

Journal of wound care
ISSN: 0969-0700
Titre abrégé: J Wound Care
Pays: England
ID NLM: 9417080

Informations de publication

Date de publication:
02 Jan 2021
Historique:
entrez: 13 1 2021
pubmed: 14 1 2021
medline: 30 6 2021
Statut: ppublish

Résumé

Management of any wound, either acute or hard-to-heal, might involve the use of multiple and different wound dressings in its treatment. This approach is necessary to overcome the myriad of clinical challenges the wound presents, as well as any underlying comorbidities that might affect the clinical outcomes. This article describes the clinical effectiveness of a coordinated wound dressing treatment regimen. This was an open-labelled non-comparative study involving patients with a variety of hard-to-heal and acute wounds of differing levels of severity, but all of which required removal of devitalised tissue to enable wound healing to progress. The first phase used the hydroresponsive wound dressing HydroClean (PAUL HARTMANN AG, Germany). The PUSH score was used as the primary measurement parameter. A total of 86 patients (38 male/48 female), with a mean age of 67.7±21.7 years, took part in the study. The results showed that the hydroresponsive dressing was effective in managing wound exudate production and promoting wound cleansing and debridement, supporting good wound bed preparation. Wound closure was observed in 16/86 (18.6%) wounds at the end of the study (20 weeks). This enabled clinicians to switch to alternative wound dressings to promote subsequent clinical healing outcomes. In this study, the hydroresponsive wound dressing was highly effective in preparing a clean wound bed such that the next stage of wound healing could be supported.

Identifiants

pubmed: 33439084
doi: 10.12968/jowc.2021.30.1.15
doi:

Types de publication

Journal Article

Langues

eng

Pagination

15-24

Auteurs

Francois Sterpione (F)

Infirmier, 3 Avenue du 08 Mai 1945, 38130 Échirolles, France.

Karine Mas (K)

Infirmière, 19 rue Paul Broca, 66100 Perpignan, France.

Mark Rippon (M)

Huddersfield University, Huddersfield, UK.
Daneriver Consultancy Ltd, Holmes Chapel, UK.

Alan Rogers (A)

Flintshire, UK.

Georges Mayeux (G)

CEN Biotech, Dijon, Bourgogne-Franche-Comté, France.

Florian Rigaudier (F)

CEN Biotech, Dijon, Bourgogne-Franche-Comté, France.

Pierre Chauvelot (P)

CEN Biotech, Dijon, Bourgogne-Franche-Comté, France.

Ludovic Robilliart (L)

Infirmier, 3 Avenue du 08 Mai 1945, 38130 Échirolles, France.

Christine Juhel (C)

CEN Biotech, Dijon, Bourgogne-Franche-Comté, France.

Yann Lecomte (Y)

CEN Biotech, Dijon, Bourgogne-Franche-Comté, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH